Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Ltd. (BHVN) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biohaven Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1935979.
Total stock buying since 2022: $57,752,127.
Total stock sales since 2022: $459,667.
Total stock option exercises since 2022: $605,865.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 32,700 | $1,001,960 | 0 | $0 | 29,500 | $0 |
| 2024 | 568,359 | $22,752,059 | 0 | $0 | 0 | $0 |
| 2023 | 1,099,634 | $23,802,668 | 11,000 | $459,667 | 11,000 | $0 |
| 2022 | 927,646 | $10,195,440 | 0 | $0 | 194,965 | $605,865 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 32,700 | $1,001,960 | 0 | $0 | 0 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 29,500 | $0 |
| 2024-10 | 42,104 | $1,999,940 | 0 | $0 | 0 | $0 |
| 2024-09 | 5,000 | $220,965 | 0 | $0 | 0 | $0 |
| 2024-07 | 28,400 | $1,012,971 | 0 | $0 | 0 | $0 |
| 2024-06 | 30,000 | $1,007,490 | 0 | $0 | 0 | $0 |
| 2024-05 | 71,500 | $2,511,579 | 0 | $0 | 0 | $0 |
| 2024-04 | 391,355 | $15,999,114 | 0 | $0 | 0 | $0 |
| 2023-12 | 0 | $0 | 11,000 | $459,667 | 11,000 | $0 |
| 2023-10 | 949,634 | $20,902,068 | 0 | $0 | 0 | $0 |
| 2023-08 | 150,000 | $2,900,600 | 0 | $0 | 0 | $0 |
| 2022-10 | 927,646 | $10,195,440 | 0 | $0 | 194,965 | $605,865 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-04 | Childs John W (Director) | Buy | 32,700 | 30.64 | 1,001,960 |
| 2025-01-05 | Buten Matthew (Chief Financial Officer) | Option Ex | 4,250 | .00 | 0 |
| 2025-01-05 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 2,500 | .00 | 0 |
| 2025-01-05 | Car Bruce (Chief Scientific Officer) | Option Ex | 4,750 | .00 | 0 |
| 2025-01-05 | Coric Vlad (Chief Executive Officer) | Option Ex | 14,250 | .00 | 0 |
| 2025-01-05 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,750 | .00 | 0 |
| 2024-10-02 | Coric Vlad (Chief Executive Officer) | Buy | 21,052 | 47.50 | 999,970 |
| 2024-10-02 | Childs John W (Director) | Buy | 21,052 | 47.50 | 999,970 |
| 2024-09-24 | Bailey Gregory (Director) | Buy | 5,000 | 44.19 | 220,965 |
| 2024-07-18 | Childs John W | Buy | 28,400 | 35.67 | 1,012,971 |
| 2024-06-17 | Car Bruce (Chief Scientific Officer) | Buy | 30,000 | 33.58 | 1,007,490 |
| 2024-05-30 | Childs John W | Buy | 28,000 | 35.58 | 996,240 |
| 2024-05-13 | Bailey Gregory | Buy | 15,000 | 34.19 | 512,880 |
| 2024-05-13 | Childs John W | Buy | 28,500 | 35.17 | 1,002,459 |
| 2024-04-24 | Bailey Gregory | Buy | 25,503 | 39.18 | 999,182 |
| 2024-04-22 | Coric Vlad (Chief Executive Officer) | Buy | 121,951 | 41.00 | 4,999,991 |
| 2024-04-22 | Bailey Gregory | Buy | 48,780 | 41.00 | 1,999,980 |
| 2024-04-22 | Childs John W | Buy | 195,121 | 41.00 | 7,999,961 |
| 2023-12-29 | Antonijevic Irina | Sale | 11,000 | 41.79 | 459,667 |
| 2023-12-29 | Antonijevic Irina | Option Ex | 11,000 | .00 | 0 |
| 2023-10-05 | Buten Matthew (Chief Financial Officer) | Buy | 22,727 | 22.00 | 499,994 |
| 2023-10-05 | Coric Vlad (Chief Executive Officer) | Buy | 454,545 | 22.00 | 9,999,990 |
| 2023-10-05 | Childs John W | Buy | 454,545 | 22.00 | 9,999,990 |
| 2023-10-04 | Bailey Gregory | Buy | 17,817 | 22.57 | 402,094 |
| 2023-08-30 | Childs John W | Buy | 50,000 | 18.44 | 922,200 |
| 2023-08-04 | Childs John W | Buy | 100,000 | 19.78 | 1,978,400 |
| 2022-10-31 | Coric Vlad (Chief Executive Officer) | Buy | 25,800 | 15.97 | 412,000 |
| 2022-10-28 | Coric Vlad (Chief Executive Officer) | Buy | 141,930 | 14.85 | 2,106,950 |
| 2022-10-05 | Coric Vlad (Chief Executive Officer) | Buy | 485,775 | 10.56 | 5,130,269 |
| 2022-10-05 | Childs John W | Buy | 274,141 | 9.29 | 2,546,221 |
| 2022-10-03 | Mehta Kishan | Option Ex | 28,121 | 3.47 | 97,636 |
| 2022-10-03 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 115,510 | 2.84 | 327,701 |
| 2022-10-03 | Heffernan Michael Thomas | Option Ex | 23,217 | 3.60 | 83,581 |
| 2022-10-03 | Gregory Julia P | Option Ex | 28,117 | 3.45 | 96,947 |
Insider trading activities including stock purchases, stock sales, and option exercises of BHVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biohaven Ltd. (symbol BHVN, CIK number 1935979) see the Securities and Exchange Commission (SEC) website.